atai Life Sciences to Participate in November Investor Events & Healthcare Conferences
NEW YORK and BERLIN, Nov. 01, 2022 (GLOBE NEWSWIRE) — atai Life Sciences N.V. (Nasdaq:ATAI) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the following investor events & healthcare conferences:
Related news for (ATAI)
- Today’s Top Performers: MoBot’s Market Review 10/17/25 07:00 PM
- MoBot alert highlights: NASDAQ: VRME, NASDAQ: ATAI, NASDAQ: STKE, NASDAQ: FGI, NASDAQ: LNKS (10/17/25 06:00 PM)
- Breaking News: MoBot’s Latest Update as of 10/17/25 05:00 PM
- MoBot’s Stock Market Highlights – 07/31/25 01:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 07/31/25 12:00 PM